Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 09/29 | 09/30 | 162,000 sh | $8.68 | $1,405,674 | +311.5% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 09/28 | 09/29 | 103,500 sh | $8.60 | $889,872.3 | +124.0% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 06/16 | 06/18 | 20,000 sh | $7.90 | $158,000 | +2.7% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 06/11 | 06/12 | 125,000 sh | $8.17 | $1,021,250 | +13.4% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 06/04 | 06/05 | 50,000 sh | $9.31 | $465,500 | +5.6% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 06/02 | 06/03 | 50,000 sh | $9.43 | $471,500 | +6.0% |
William P. Scully10% Owner | Prothena Corp PublicPRTA | Open-market buy | 05/22 | 05/26 | 100,000 sh | $9.81 | $981,000 | +13.6% |
Prothena Corp PublicPRTA | Open-market sale | 25/05/02–25/05/06 | 25/05/06 | 6,279,684 sh3 trades | $8.09avg. | $50,825,216.83 | −54.2% | |
Prothena Corp PublicPRTA | Open-market buy | 24/12/18–25/01/14 | 25/05/02 | 207,436 sh6 trades | $13.26avg. | $2,750,239.48 | +39.2% | |
Karin L. WalkerChief Accounting Officer | Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 24/01/24 | 24/01/24 | 5,000 sh | $34.00 | $170,000 | −100.0% |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/12/20 | 23/12/20 | 5,000 sh2 trades | $37.19avg. | $185,957.94 | −100.0% | |
Karin L. WalkerChief Accounting Officer | Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/11/30 | 23/11/30 | 5,000 sh | $34.00 | $170,000 | −100.0% |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/10/25 | 23/10/25 | 5,000 sh3 trades | $41.04avg. | $205,178.81 | −100.0% | |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/10/11 | 23/10/11 | 4,000 sh2 trades | $46.74avg. | $186,977.28 | −100.0% | |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/10/04 | 23/10/04 | 5,000 sh2 trades | $46.61avg. | $233,067.14 | −100.0% | |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/09/27 | 23/09/27 | 5,000 sh2 trades | $47.37avg. | $236,862.08 | −100.0% | |
Karin L. WalkerChief Accounting Officer | Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/09/19 | 23/09/19 | 5,000 sh | $52.36 | $261,800 | −100.0% |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/09/13 | 23/09/13 | 4,000 sh2 trades | $55.49avg. | $221,974.72 | −100.0% | |
Hideki GarrenChief Medical Officer | Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/09/13 | 23/09/13 | 2,000 sh | $55.48 | $110,960 | −100.0% |
Prothena Corp PublicPRTA | Open-market sale10b5-1 plan | 23/09/06 | 23/09/06 | 5,000 sh2 trades | $54.76avg. | $273,803.06 | −100.0% |